FDA Slams Centurion For Lax Data Integrity And Misplaced Priorities
Executive Summary
The US FDA lambasts Indian drug manufacturer Centurion Laboratories for misplaced priorities and data integrity failings. Workers left product residue on equipment while away for dancing festival. Out-of-specification stability testing results were torn, bagged and replaced with passing results.